UCFA
ASND icon

United Capital Financial Advisors’s Ascendis Pharma A/S ASND Stock Holding History

United Capital Financial Advisors’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8,830
Closed -$1.47M – 1184
2020
Q4 		$1.47M Sell
8,830
-2,149
-20% -$355K 0.01% 578
2020
Q3 		$1.69M Sell
10,979
-6,874
-39% -$988K 0.01% 538
2020
Q2 		$2.64M Buy
+17,853
New +$2.45M 0.02% 460

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

United Capital Financial Advisors's ASND Position: Q1 2021 in Review

United Capital Financial Advisors sold out of Ascendis Pharma A/S (ASND) in Q1 2021, closing a stake of 8,830 shares — an estimated $1.47M sold.

United Capital Financial Advisors first reported a position in ASND in Q2 2020 and held it in 3 quarters. The position peaked at $2.64M in Q2 2020. 177 funds tracked by Wall St. Rank hold ASND as of Q1 2021.

  • United Capital Financial Advisors reported no remaining Ascendis Pharma A/S position as of Q1 2021 after selling out during the quarter.
  • United Capital Financial Advisors sold 8,830 Ascendis Pharma A/S shares in Q1 2021, an estimated $1.47M.
  • United Capital Financial Advisors first reported a position in Ascendis Pharma A/S in Q2 2020 and held it in 3 quarters.
  • United Capital Financial Advisors's Ascendis Pharma A/S position peaked at $2.64M in Q2 2020.
  • 177 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2021.

Based on United Capital Financial Advisors's 13F filing for Q1 2021, filed 14 May 2021.